北京大学学报(医学版) ›› 2016, Vol. 48 ›› Issue (5): 771-776. doi: 10.3969/j.issn.1671-167X.2016.05.004

• 论著 • 上一篇    下一篇

CD40 siRNA对 MRL/Lpr狼疮小鼠炎症反应的影响

王志华1,张伟1,张艳清1,庞春艳2△,王永福1△   

  1. (1.包头医学院第一附属医院风湿免疫科,内蒙古自治区包头014010;2. 内蒙古自治区自体免疫学重点实验室,内蒙古自治区包头014010)
  • 出版日期:2016-10-18 发布日期:2016-10-18
  • 通讯作者: 庞春艳,王永福 E-mail:pchy_fighting@163.com, wyf5168@hotmail.com
  • 基金资助:

    国家自然科学基金(30960354)资助

Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice

WANG Zhi-hua1, ZHANG Wei1, ZHANG Yan-qing1, PANG Chun-yan2Δ,WANG Yong-fu1Δ   

  1. (1.Department of Rheumatology, the First Affiliated Hospital of Baotou Medical College, Baotou 014010, Inner Mogolia, China; 2. Key Autoimmunity Lab of Inner Mongolia, Baotou 014010, Inner Mogolia, China)
  • Online:2016-10-18 Published:2016-10-18
  • Contact: PANG Chun-yan,WANG Yong-fu E-mail:pchy_fighting@163.com, wyf5168@hotmail.com
  • Supported by:

    Supported by the National Natural Science Foundation of China (30960354)

摘要:

目的:观察CD40的小干扰RNA(small interfering RNA, siRNA)对系统性红斑狼疮(systemic lupus erythematosus, SLE)动物模型MRL/Lpr小鼠细胞因子IFNγ、IL17、IL-4和抗双链DNA(anti-double strand DNA,anti-ds-DNA)抗体表达水平的影响,探讨CD40 siRNA治疗MRL/Lpr小鼠的可能性。方法:16只MRL/Lpr小鼠随机分为对照组、空载体组、CD40-siRNA1组及CD40-siRNA2组,每组4只,将成功构建的CD40 siRNA表达载体尾静脉注射MRL/Lpr小鼠,对照组和空载体组小鼠分别注射等剂量、等比例的磷酸盐缓冲液(PBS)和pGFP-V-RS空载体,每隔1天1次,共6次,14 d处死小鼠,称其脾的质量,组织切片在荧光显微镜下观察小鼠脾是否有CD40 siRNA的表达,注射前及注射后第2、5、8、11和14 天小鼠尾部采血,ELISA法检测4组小鼠血清中IFN-γ、IL-17、IL-4和anti-dsDNA抗体的表达水平变化, RT-PCR法检测小鼠脾组织中CD40 mRNA的表达水平,免疫组织化学法检测小鼠脾组织中CD40蛋白的表达水平。结果:注射后的siRNA表达载体可以在小鼠脾中表达;注射CD40 siRNA组的小鼠脾质量减轻,由对照组(141.88±7.81) mg和空载体组(153.10±7.60) mg降低至CD40-siRNA1组(78.85 ±5.61) mg和CD40-siRNA2组(80.25±4.07) mg,注射前4组小鼠血清中IFN-γ、IL-17、IL-4和anti-dsDNA抗体的(质量)浓度比较,差异无统计学意义;而注射后第2、5和8天 CD40-siRNA1组和CD40-siRNA2组MRL/Lpr小鼠血清中IFN-γ、IL-17和(质量)浓度明显下降,CD40-siRNA1组的IFN-γ的(质量)浓度依次为(118.74±10.32) ng/L(pg/mL)、 (115.24±8.26) ng/L、(113.71±5.02) ng/L ,CD40-siRNA2组依次为(117.83±6.83) ng/L 、(114.07±0.97) ng/L、(112.67±9.66) ng/L; CD40-siRNA1组的IL-17的(质量)浓度依次为(7.05±0.41) ng/L、(6.34±0.76) ng/L、(5.83±0.43) ng/L,CD40-siRNA2组依次为(7.07±0.22) ng/L、(6.35±0.49) ng/L、(6.12±0.80) ng/L;CD40-siRNA1组的anti-dsDNA的浓度依次为(7.51±0.29) ng/L、(6.74±0.45) ng/L、(6.32±0.39) ng/L;CD40-siRNA2组依次为(8.19±0.38) ng/L、(7.14±0.50) ng/L、(6.48±0.29) ng/L。IL-4的(质量)浓度明显升高,CD40-si-RNA1组IL-4的(质量)浓度依次为(26.51±1.81) ng/L、(27.80±1.72) ng/L、(28.08±2.21) ng/L,CD40-siRNA2组依次为(26.28±2.03) ng/L、(28.15±2.95) ng/L、(28.37±1.71) ng/L。 CD40-siRNA1组和CD40-siRNA2组与对照组和空载体组比较差异有统计学意义(P<0.05), 注射后第11和14天 CD40siRNA1组和CD40-siRNA2组中这4个指标的(质量)浓度逐渐恢复至对照组和空载体组的(质量)浓度水平,IFN-γ、 IL-17、IL-4的(质量)浓度4组小鼠比较,差异无统计学意义,注射后第11天 CD40-siRNA1组和CD40-siRNA2组anti-dsDNA抗体的水平尽管与对照组和空载体组比较有所提高,4组比较差异有统计学意义(P<0.05),而注射后第14天 anti-dsDNA抗体的水平4组小鼠比较,差异无统计学意义。注射后第14天 CD40-siRNA1组和CD40-siRNA2组 MRL/Lpr小鼠脾组织中CD40 mRNA和蛋白的表达水平明显低于对照组和空载体组,差异有统计学意义(P<0.05)。结论: MRL/Lpr小鼠注射CD40 siRNA载体后,血清中IFN-γ、IL17和anti-dsDNA抗体水平降低,IL-4的浓度升高,CD40 mRNA和蛋白的表达水平下降,说明CD40 siRNA抑制其mRNA和蛋白后,MRL/Lpr小鼠炎症反应减轻,疾病活动度下降,提示其对SLE动物模型MRL/Lpr小鼠有治疗作用。

关键词: 抗原, CD40, RNA, 小分子干扰, 红斑狼疮, 系统性, 细胞因子类, 小鼠, 近交MRL Lpr

Abstract:

Objective:To observe the effect of CD40 siRNA on expression of IFN-γ, IL-17,  IL-4 and anti-dsDNA antibody of systemic lupus erythematosus (SLE) animal model MRL/Lpr mice and to discuss its therapy on MRL/Lpr mice. Methods: In the study, 16 female MRL/Lpr mice were randomly divided into control group (n=4), empty vector group (n=4), CD40siRNA1 group (n=4) and CD40-siRNA2 group (n=4). The vectors expressing siRNA against CD40 were injected by tail veil into MRL/Lpr mice, while MRL/Lpr mice in control group and empty vector group were injected with the same dose of PBS and pGFP-V-RS vector respectively.  The injection was given six times and every one day. The mice were sacrificed  14 d after injection, and the spleen tissue was weighed. The pGFP-V-RS was labeled by green fluorescent protein(GFP) and the tissue sections were observed whether siRNA expressed in the spleen. The expression levels of IFN-γ, IL-17, IL-4 and anti-dsDNA antibody in the sera were detected by ELISA method on the 1st day before the first time and the 2nd, 5th, 8th, 11th, and 14th days after last  injection, and the expression levels of CD40 mRNA in spleen tissue of MRL/Lpr mice were detected by RT-PCR and the expression levels of CD40 protein in spleen tissue of MRL/Lpr mice were detected by immunohistochemistry method. Results: The expression vector of CD40-siRNA could express in the spleen of MRL/Lpr. The spleens in CD40-siRNA1 group [(78.85 ±5.61) mg] and CD40-siRNA2 group [(80.25±4.07) mg] were lower than those in control  [(141.88±7.81) mg] and empty vector group [(153.10±7.60) mg]. The levels of IL-17, IFN-γ and anti-dsDNA antibody were lower and the levels of IL-4 was higher in CD40-siRNA1 group and CD40-siRNA2 group on the 2nd, 5th and 8th days after last injection than on the 1st day before the first time (P<0.05). The levels of IFN-γ in CD40-siRNA1 group were (118.74±10.32) ng/L, (115.24±8.26) ng/L and (113.71±5.02) ng/L in turn, the levels of IFNγ in CD40siRNA2 group were (117.83±6.83) ng/L, (114.07±0.97) ng/L and (112.67±9.66) ng/L in turn. The levels of IL-17 in CD40-siRNA1 group were (7.05±0.41) ng/L, (6.34±0.76) ng/L and (5.83±0.43) ng/L in turn, the levels of IL-17 in CD40-siRNA2 group were (7.07±0.22) ng/L, (6.35±0.49) ng/L and (6.12±0.80) ng/L in turn. The levels of anti-dsDNA antibody in CD40-siRNA1 group were (7.51±0.29) ng/L, (6.74±0.45) ng/L and (6.32±0.39) ng/L  in turn, the levels of anti-dsDNA antibody in CD40-siRNA2 group were (8.19±0.38) ng/L, (7.14±0.50) ng/L and (6.48±0.29) ng/L in turn. The levels of IL-4 in CD40siRNA1 group were (26.51±1.81)ng/L  (27.80±1.72) ng/L  and (28.08±2.21) ng/L  in turn, the level of IL-4 in CD40-siRNA2 group were (26.28±2.03) ng/L, (28.15±2.95) ng/L and (28.37±1.71) ng/L in turn. The expression  levels of IL-17 and IFN-γ antibody increased gradually and the levels of IL-4 decreased gradually in CD40-siRNA1 group and CD40-siRNA2 group on the 11th and 14th days after last injection, then reached to the levels of control group and empty vector group (P>0.05). Though the levels of anti-dsDNA antibody in CD40-siRNA1 group and CD40-siRNA2 group on the 11th day was higher than on the 8th day, there was more significance than those in control group and empty vector group (P<0.05). There was no significance between the 4 groups on the 14th day. The levels of CD40 mRNA and protein were lower in CD40-siRNA1 group and CD40-siRNA2 group than in control group and empty vector group on the 14th day after last injection (P<0.05). Conclusion: CD-40 si-RNA can reduce the concentration of IL-17, IFN-γ and of anti-dsDNA antibody in serum, and at the same time, it can elevate the concentration of IL-4 and suppress CD40 mRNA and protein of spleen in MRL/Lpr. Meanwhile after suppressing CD40 mRNA and protein, it can reduce inflammatory response of the mice and the disease activity of MRL/Lpr, suggesting that CD-40 siRNA has therapy effect on SLE.

Key words: Antigens, CD40, RNA, small interfering, Lupus erythematosus, systemic, Cytokines, Mice, inbred MRL Lpr

中图分类号: 

  •  
[1] 田佳宜,张霞,程功,刘庆红,王世阳,何菁. 系统性红斑狼疮患者血清白细胞介素-2受体α水平及其临床意义[J]. 北京大学学报(医学版), 2021, 53(6): 1083-1087.
[2] 娄雪,廖莉,李兴珺,王楠,刘爽,崔若玫,徐健. 类风湿关节炎患者外周血TWEAK基因启动子区甲基化状态及其表达[J]. 北京大学学报(医学版), 2021, 53(6): 1020-1025.
[3] 贾睿璇,姜尚伟,赵琳,杨丽萍. Cyp4v3基因敲除小鼠模型的表型分析[J]. 北京大学学报(医学版), 2021, 53(6): 1099-1106.
[4] 邹健梅,武丽君,罗采南,石亚妹,吴雪. 血清25-羟维生素D与系统性红斑狼疮活动的关系[J]. 北京大学学报(医学版), 2021, 53(5): 938-941.
[5] 李正芳,吴雪,武丽君,罗采南,石亚妹,钟岩,陈晓梅,孟新艳. Rhupus综合征的临床特点[J]. 北京大学学报(医学版), 2021, 53(5): 933-937.
[6] 马向波,张学武,贾汝琳,高颖,刘洪江,刘玉芳,李英妮. 外周血淋巴细胞亚群检测在系统性硬化症治疗中的应用[J]. 北京大学学报(医学版), 2021, 53(4): 721-727.
[7] 朱忆颖,闵赛南,俞光岩. 局部注射环孢素A对非肥胖糖尿病小鼠下颌下腺分泌功能及炎症的影响[J]. 北京大学学报(医学版), 2021, 53(4): 750-757.
[8] 夏芳芳,鲁芙爱,吕慧敏,杨国安,刘媛. 系统性红斑狼疮伴间质性肺炎的临床特点及相关因素分析[J]. 北京大学学报(医学版), 2021, 53(2): 266-272.
[9] 赵静,孙峰,李云,赵晓珍,徐丹,李英妮,李玉慧,孙晓麟. 抗α-1C微管蛋白抗体在系统性硬化症中的表达及临床意义[J]. 北京大学学报(医学版), 2020, 52(6): 1009-1013.
[10] 郭倩, 马晓旭, 高辉, 石连杰, 钟昱超, 谢琳峰, 邵苗, 张学武. Semaphorin 3A在系统性红斑狼疮合并血小板减少患者中的水平及意义[J]. 北京大学学报(医学版), 2020, 52(5): 892-896.
[11] 王晓,贺丹,李文婷,阿迪拉·斯依提,韩蕊,董颖. 144例维吾尔族与汉族女性子宫内膜癌微小RNA表达特点及临床意义[J]. 北京大学学报(医学版), 2020, 52(3): 570-577.
[12] 朱梅青,崔蓉. 高效液相色谱法测定小鼠血浆中苯并三唑类紫外线吸收剂UV-327和UV-328[J]. 北京大学学报(医学版), 2020, 52(3): 591-596.
[13] 孙奎霞,闫存玲,李志艳,刘平,张伟,何群. 前列腺特异性抗原同源异构体2及其衍生指标在预测前列腺癌病理分级中的价值[J]. 北京大学学报(医学版), 2020, 52(2): 234-239.
[14] 耿研,李伯睿,张卓莉. 系统性红斑狼疮患者有症状关节病变的肌肉骨骼超声特点[J]. 北京大学学报(医学版), 2020, 52(1): 163-168.
[15] 李英妮,相晓红,赵静,李云,孙峰,王红彦,贾汝琳,胡凡磊. 抗类瓜氨酸化抗体在系统性红斑狼疮中的意义[J]. 北京大学学报(医学版), 2019, 51(6): 1019-1024.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[4] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[5] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[6] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[7] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[8] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .
[9] 丰雷, 王玉凤, 曹庆久. 哌甲酯对注意缺陷多动障碍儿童平衡功能影响的开放性研究[J]. 北京大学学报(医学版), 2007, 39(3): 304 -309 .
[10] 刘津, 王玉凤. 父母培训对共患对立违抗性障碍的注意缺陷多动障碍的作用[J]. 北京大学学报(医学版), 2007, 39(3): 310 -314 .